Chemoprevention with the Combination of Ginsenoside Rd, Vitamin D3 and Metformin on Colitis-Associated Colon Neoplasia in Mice

Xia Liu,Wei-Hu Yang,Wei Han,Chun-Lan Yang,Li-Wang,Yong-Jie Wu
2020-01-01
Latin american journal of pharmacy
Abstract:Ginsenoside Rd (GRd) is a protopanaxadiol-type ginsenoside found in ginseng whose antitumor activities have been reported. We previously reported the chemoprevention of vitamin D3 (VD3) and metformin (Met) in mice and rat models of colorectal carcinogenesis. Here we investigated the potential synergistic chemoprevention of GRd, VD3, and Met on colitis-associated colon neoplasia induced with 1,2-dimethylhydrazine dihydrochloride (DMH) via intraperitoneal injection, and dextran sodium sulfate (DSS) in the drinking water. Our results showed that combination of GRd, VD3, and Met treatment exhibit synergistic effects against the early colon cancer, as evidenced by reduced the numbers of aberrant crypt foci (ACF) and tumor in the colon of mice. The possible mechanism of their action was associated with downregulation S6P expression via the AMPK/mTOR pathway. These results suggest that the combination of GRd, VD3, and Met may prevent colon cancer associated with colitis.
What problem does this paper attempt to address?